Table 1—
Comparison of baseline characteristics between participants who developed dysglycemia during the 9-year follow-up and those who did not: results of bivariate analyses
| Participants
|
P value | ||
|---|---|---|---|
| Did not develop dysglycemia | Developed dysglycemia | ||
| n | 1,038 | 127 | |
| Sociodemographic factors | |||
| Women | 63.9 | 44.7 | <10−4 |
| Age at baseline (years) | 65.0 ± 3.0 | 64.9 ± 3.1 | 0.72 |
| Higher education* | 48.5 | 47.1 | 0.78 |
| Consumption factors | |||
| Current/former smokers | 38.7 | 52.8 | 0.002 |
| Alcohol consumer (>20 ml/day)* | 26.0 | 39.2 | 0.002 |
| Health factors | |||
| BMI (kg/m2)* | 24.7 ± 3.4 | 27.0 ± 3.7 | <10−4 |
| HDL cholesterol (mmol/l)* | 1.69 ± 0.43 | 1.50 ± 0.42 | <10−4 |
| Total cholesterol (mmol/l)* | 6.43 ± 1.01 | 6.30 ± 0.98 | 0.17 |
| Total-to-HDL cholesterol ratio* | 4.03 ± 1.15 | 4.49 ± 1.45 | 0.01 |
| Lipid-lowering drugs user | 22.8 | 27.6 | 0.23 |
| Systolic blood pressure (mmHg)* | 130.0 ± 17.6 | 136.4 ± 16.0 | 0.0001 |
| Diastolic blood pressure (mmHg)* | 78.4 ± 10.8 | 82.0 ± 11.1 | 0.0006 |
| Cardiovascular disease antecedents | 8.6 | 8.9 | 0.91 |
| Total plasma carotenoid (μmol/l) | 2.87 ± 1.29 | 2.37 ± 1.10 | <10−4 |
Data are means ± SD or percent.
*
Analyses were performed on 1,164 participants for education level, 1,144 for alcohol consumption, 1,164 for blood pressure, 1,162 for BMI, 1,121 for LDL cholesterol, 1,130 for HDL cholesterol, and 1,139 for total cholesterol.